Positioning biologics in the treatment of IBD: A practical guide
Adalimumab
Biological therapy
Infliximab
Monoclonal antibodies
Ustekinumab
Vedolizumab
Journal
Current research in pharmacology and drug discovery
ISSN: 2590-2571
Titre abrégé: Curr Res Pharmacol Drug Discov
Pays: Netherlands
ID NLM: 9918300982506676
Informations de publication
Date de publication:
2022
2022
Historique:
received:
12
01
2022
revised:
04
04
2022
accepted:
24
04
2022
entrez:
16
5
2022
pubmed:
17
5
2022
medline:
17
5
2022
Statut:
epublish
Résumé
The number of available biological therapies have doubled over the last 10 years and the arrival of novel molecules (interleukin 23p19 inhibitors) is ongoing alongside the development of small molecules. As a result of this vast landscape of treatment, positioning advanced therapies (according to clinical situation, efficacy and safety) is of paramount importance to providing personalized, appropriate IBD treatment. In this publication the recent available literature is summarized for practical integration into clinical practice including comparative efficacy data, patient and disease demographics. We refer to recent publications and expert opinion in order to facilitate the decision making process of positioning biologicals IBD treatment.
Identifiants
pubmed: 35570855
doi: 10.1016/j.crphar.2022.100104
pii: S2590-2571(22)00024-4
pmc: PMC9092374
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
100104Informations de copyright
© 2022 The Authors. Published by Elsevier B.V.
Déclaration de conflit d'intérêts
Pascal Juillerat received consulting fees from AbbVie, Arena Pharma, Amgen, BMS, Ferring, Gilead, Janssen, Lilly, MSD, Pfizer, Pierre Fabre, Roche, Takeda, and Vifor Pharma. Lecture fees from AbbVie, Amgen, Janssen, Pfizer, Takeda, UCB pharma and Vifor Pharma and research grants from Vifor Pharma. Maude Martinho Grueber, Roseline Ruetsch, Giulia Santi and Marianne Vullièmoz have no conflict of interest to declare. Pierre Michetti received consulting fees from AstraZeneca, AbbVie, Ferring Pharmaceuticals, Janssen, MSD, Nestlé Health Sciences, Pfizer, Pierre Fabre, Takeda, UCB Pharma, and Vifor Pharma, lecture fees from Ferring Pharmaceuticals, Janssen, Hospira, MSD, Pfizer, Takeda, UCB Pharma, and Vifor Pharma and research grants from iQone.
Références
Aliment Pharmacol Ther. 2018 Mar;47(6):753-762
pubmed: 29377235
Gastroenterol Hepatol (N Y). 2020 Feb;16(2):75-81
pubmed: 34035705
J Crohns Colitis. 2020 Jan 1;14(1):4-22
pubmed: 31711158
Clin Gastroenterol Hepatol. 2020 Jan;18(1):179-187.e6
pubmed: 31100458
Gastroenterology. 2007 Mar;132(3):863-73; quiz 1165-6
pubmed: 17324398
J Crohns Colitis. 2015 Dec;9(12):1120-6
pubmed: 26351386
Am J Gastroenterol. 2018 Jun;113(6):883-889
pubmed: 29867171
Immunity. 2019 Aug 20;51(2):367-380.e4
pubmed: 31350179
Gastroenterology. 2014 Feb;146(2):383-91
pubmed: 24162032
PLoS Med. 2020 Oct 30;17(10):e1003348
pubmed: 33125391
Nat Rev Gastroenterol Hepatol. 2021 Aug;18(8):544-558
pubmed: 33712743
J Crohns Colitis. 2020 Jun 19;14(5):694-709
pubmed: 31777929
Clin Gastroenterol Hepatol. 2020 May;18(6):1367-1380
pubmed: 31712084
Gastroenterol Hepatol (N Y). 2022 Apr;18(4 Suppl 1):9-10
pubmed: 35610992
Gastroenterology. 2021 Jan;160(1):470-471
pubmed: 33022279
Aliment Pharmacol Ther. 2010 Jan;31(1):92-101
pubmed: 19709098
Aliment Pharmacol Ther. 2018 Jan;47(2):162-175
pubmed: 29205406
Am J Gastroenterol. 2021 May 1;116(5):1007-1014
pubmed: 33929379
Inflamm Bowel Dis. 2012 Jan;18(1):1-9
pubmed: 21351211
Ann Pharmacother. 2020 Aug;54(8):729-741
pubmed: 31955605
Gut. 2018 Jan;67(1):53-60
pubmed: 28119352
Gastroenterology. 2014 Jan;146(1):85-95; quiz e14-5
pubmed: 23735746
J Gastroenterol. 2017 Jul;52(7):788-799
pubmed: 27722996
Lancet. 2022 Jun 11;399(10342):2200-2211
pubmed: 35691323
J Crohns Colitis. 2008 Sep;2(3):219-25
pubmed: 21172214
Gastroenterology. 2007 Jan;132(1):52-65
pubmed: 17241859
Lancet. 2016 Jan 9;387(10014):156-67
pubmed: 26490195
Ann Rheum Dis. 2020 Jun;79(6):744-759
pubmed: 32033937
Clin Gastroenterol Hepatol. 2016 Oct;14(10):1385-1397.e10
pubmed: 27189910
Gastroenterol Hepatol. 2018 Nov;41(9):576-582
pubmed: 30054143
Gastroenterology. 2022 Feb;162(2):482-494
pubmed: 34757139
Am J Gastroenterol. 2022 Jul 1;117(7):1106-1117
pubmed: 35435862
J Crohns Colitis. 2018 May 25;12(6):635-643
pubmed: 29370397
J Clin Med. 2021 Nov 26;10(23):
pubmed: 34884247
Gastroenterology. 2022 May;162(6):1650-1664.e8
pubmed: 35134323
Clin Gastroenterol Hepatol. 2022 Jul;20(7):1579-1587.e2
pubmed: 33838348
J Pediatr Gastroenterol Nutr. 2021 Nov 1;73(5):610-614
pubmed: 34415711
Cochrane Database Syst Rev. 2019 Aug 29;8:CD012893
pubmed: 31476018
J Crohns Colitis. 2012 Mar;6(2):143-53
pubmed: 22325168
N Engl J Med. 2021 Aug 12;385(7):628-639
pubmed: 34379924
United European Gastroenterol J. 2021 Apr;9(3):398-406
pubmed: 33203339
Scand J Gastroenterol. 2019 Feb;54(2):188-193
pubmed: 30739519
Lancet Gastroenterol Hepatol. 2022 Jan;7(1):17-27
pubmed: 34798036
Nat Rev Gastroenterol Hepatol. 2020 Nov;17(11):702-710
pubmed: 32879465
Inflamm Bowel Dis. 2017 Jan;23(1):97-106
pubmed: 27930408
Clin Gastroenterol Hepatol. 2017 Feb;15(2):229-239.e5
pubmed: 27639327
Am J Gastroenterol. 2011 Jan;106(1):110-9
pubmed: 20808297
Clin Gastroenterol Hepatol. 2016 Aug;14(8):1120-1129.e6
pubmed: 27058635
Clin Gastroenterol Hepatol. 2015 Mar;13(3):531-8
pubmed: 25117777
Inflamm Bowel Dis. 2018 Aug 16;24(9):1876-1882
pubmed: 29668916
Lancet Gastroenterol Hepatol. 2022 Feb;7(2):128-140
pubmed: 34798039
Digestion. 2020;101 Suppl 1:83-97
pubmed: 32066137
Aliment Pharmacol Ther. 2016 Sep;44(6):554-67
pubmed: 27417569
Digestion. 2020;101 Suppl 1:105-119
pubmed: 31935714
Gastroenterology. 2014 Sep;147(3):618-627.e3
pubmed: 24859203
J Crohns Colitis. 2016 Oct 20;11(3):263-273
pubmed: 27797918
Aliment Pharmacol Ther. 2020 Oct;52(8):1366-1376
pubmed: 32901983
Adv Ther. 2018 Apr;35(4):563-576
pubmed: 29516410
Am J Gastroenterol. 2011 Apr;106(4):590-9; quiz 600
pubmed: 21407179
Am J Gastroenterol. 2002 Oct;97(10):2688-90
pubmed: 12385472
Aliment Pharmacol Ther. 2015 Mar;41(5):419-28
pubmed: 25580985
Curr Res Pharmacol Drug Discov. 2022 Mar 03;3:100095
pubmed: 35281692
Lancet Gastroenterol Hepatol. 2021 Jul;6(7):589-595
pubmed: 34019798
J Gastroenterol Hepatol. 2021 Jan;36(1):105-111
pubmed: 32428981
Ann Intern Med. 2014 May 20;160(10):704-11
pubmed: 24842416
Ann Gastroenterol. 2020 Mar-Apr;33(2):170-177
pubmed: 32127738
Curr Gastroenterol Rep. 2020 Jun 15;22(8):36
pubmed: 32542562
Gastroenterology. 2021 Jun;160(7):2512-2556.e9
pubmed: 34051985
Am J Gastroenterol. 2002 Sep;97(9):2357-63
pubmed: 12358256
Dig Liver Dis. 2020 Dec;52(12):1461-1466
pubmed: 32601033
J Pediatr Gastroenterol Nutr. 2019 Jul;69(1):82-87
pubmed: 30789863
Gut. 2019 May;68(5):814-828
pubmed: 29848778
United European Gastroenterol J. 2020 Oct;8(8):933-941
pubmed: 32631177
Clin Gastroenterol Hepatol. 2022 May;20(5):1059-1067.e9
pubmed: 34597729
J Gastrointestin Liver Dis. 2016 Mar;25(1):49-56
pubmed: 27014753
South Med J. 2015 Mar;108(3):139-43
pubmed: 25772045
Clin Drug Investig. 2021 Oct;41(10):917-925
pubmed: 34537921
J Crohns Colitis. 2020 Oct 5;14(10):1488-1493
pubmed: 32318735
Aliment Pharmacol Ther. 2018 Feb;47(4):454-465
pubmed: 29205421
Cochrane Database Syst Rev. 2020 May 16;5:CD012877
pubmed: 32413933
Clin Gastroenterol Hepatol. 2022 Jul;20(7):1588-1597.e3
pubmed: 34329776
Gastroenterology. 2015 Feb;148(2):344-54.e5; quiz e14-5
pubmed: 25448924
Nat Rev Gastroenterol Hepatol. 2020 Jun;17(6):365-376
pubmed: 32303700
Dig Liver Dis. 2020 Oct;52(10):1148-1155
pubmed: 32828693
Am J Gastroenterol. 2010 Jul;105(7):1574-82
pubmed: 20234346
Gastroenterology. 2020 Jun;158(8):2104-2111.e2
pubmed: 32105728
Ann Rheum Dis. 2004 Dec;63(12):1664-9
pubmed: 15297279
Clin Gastroenterol Hepatol. 2014 Mar;12(3):434-42.e1
pubmed: 23978351
J Crohns Colitis. 2022 Jan 28;16(1):2-17
pubmed: 34635919
Clin Gastroenterol Hepatol. 2020 Mar;18(3):620-627.e1
pubmed: 31202984
Aliment Pharmacol Ther. 2010 Mar;31(5):561-72
pubmed: 19958311
N Engl J Med. 2004 Feb 26;350(9):876-85
pubmed: 14985485
Dermatology. 2022;238(4):785-792
pubmed: 34710873
N Engl J Med. 2019 Sep 26;381(13):1215-1226
pubmed: 31553834
Inflamm Bowel Dis. 2019 Jan 1;25(1):67-73
pubmed: 29889230
Expert Rev Gastroenterol Hepatol. 2015 May;9(5):693-700
pubmed: 25763862
Lancet Gastroenterol Hepatol. 2022 Feb;7(2):118-127
pubmed: 34798038
Clin Gastroenterol Hepatol. 2021 May;19(5):939-946.e4
pubmed: 32371165
J Clin Med. 2021 Nov 29;10(23):
pubmed: 34884344
Gastroenterology. 2020 Jan;158(1):189-199
pubmed: 31600487
J Med Econ. 2015 Jun;18(6):437-46
pubmed: 25629655
Aliment Pharmacol Ther. 2018 Aug;48(4):394-409
pubmed: 29920733
Front Med (Lausanne). 2019 May 24;6:104
pubmed: 31179280
United European Gastroenterol J. 2019 Dec;7(10):1285-1303
pubmed: 31839954
Dermatology. 2007;215(3):245-51
pubmed: 17823524